Structural basis for the action of the drug trametinib at KSR-bound MEKZ.M. Khan, Arvin C. Dar, Mary E. Duffy et al.|Nature|2020Cited by 172
A whole-animal platform to advance a clinical kinase inhibitor into new disease spaceMasahiro Sonoshita, Arvin C. Dar, Matthew A. Murray et al.|Nature Chemical Biology|2018Cited by 73
Type II Binders Targeting the “GLR-Out” Conformation of the Pseudokinase STRADαRyan H. B. Smith, Arvin C. Dar, Seshat M. Mack et al.|Biochemistry|2021Cited by 7
Ploidy Leads a Molecular Motor to Walk Different Paths to Drug ResistanceAlexander M. Real, Arvin C. Dar, William M. Marsiglia|Cell chemical biology|2020Cited by 3